{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:56:36Z","timestamp":1773982596750,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T00:00:00Z","timestamp":1639267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.12.015","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T17:24:56Z","timestamp":1640625896000},"page":"640-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh"],"prefix":"10.1016","volume":"40","author":[{"given":"Fahima","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afroza","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taufiqur Rahman","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imam","family":"Tauheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-9104","authenticated-orcid":false,"given":"Samuel","family":"Teshome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arijit","family":"Sil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima Raiyan","family":"Basher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faez","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahbubul","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mainul","family":"Ahasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masudur Rahman","family":"Mia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir Mohammad Ibna","family":"Masud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Wahab","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masum","family":"Billah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zebun","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Muktadir Rahman","family":"Ashik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Digilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Excler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10001","key":"10.1016\/j.vaccine.2021.12.015_b0005","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(15)61140-0","article-title":"Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial","volume":"386","author":"Qadri","year":"2015","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.015_b0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.12.015_b0015","doi-asserted-by":"crossref","unstructured":"Schwartz, B.S., et al., Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. Am J Tropical Med Hygiene, 2006. 74(6): p. 1067-1073.","DOI":"10.4269\/ajtmh.2006.74.1067"},{"key":"10.1016\/j.vaccine.2021.12.015_b0020","doi-asserted-by":"crossref","unstructured":"Chowdhury, F., et al., A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr Infect Dis J, 2008. 27(11): p. 986-92.","DOI":"10.1097\/INF.0b013e3181783adf"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.015_b0025","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1371\/journal.pntd.0000173","article-title":"The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa","volume":"2","author":"Deen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2021.12.015_b0030","doi-asserted-by":"crossref","unstructured":"Glass, R.I., et al., Endemic cholera in rural Bangladesh, 1966\u20131980. Am J Epidemiol, 1982. 116(6): p. 959-970.","DOI":"10.1093\/oxfordjournals.aje.a113498"},{"key":"10.1016\/j.vaccine.2021.12.015_b0035","doi-asserted-by":"crossref","unstructured":"WHO, Cholera vaccines: WHO position paper\u2014Recommendations. Vaccine, 2010. 28(30): p. 4687-4688.","DOI":"10.1016\/j.vaccine.2010.05.008"},{"key":"10.1016\/j.vaccine.2021.12.015_b0040","unstructured":"Bangladesh begins 1st nationwide anti-cholera drive. 20 February 2020 [cited 2021 18 November]; Available from: https:\/\/www.outlookindia.com\/newsscroll\/bangladesh-begins-1st-nationwide-anticholera-drive\/1739115."},{"issue":"8","key":"10.1016\/j.vaccine.2021.12.015_b0045","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2021.12.015_b0050","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1016\/j.vaccine.2019.12.011","article-title":"Current and future cholera vaccines","volume":"38","author":"Shaikh","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.015_b0055","unstructured":"Bangladesh - Current expenditure on health per capita. [cited 2021 16 November]; Available from: https:\/\/knoema.com\/atlas\/Bangladesh\/topics\/Health\/Health-Expenditure\/Health-expenditure-per-capita."},{"issue":"51","key":"10.1016\/j.vaccine.2021.12.015_b0060","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.vaccine.2013.10.021","article-title":"Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh","volume":"31","author":"Khan","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.015_b0065","unstructured":"VACCINATION OFFERED - Evercare Hospital Dhaka. [cited 2021 16 November]; Available from: https:\/\/www.evercarebd.com\/vaccination-centre\/."},{"key":"10.1016\/j.vaccine.2021.12.015_b0070","unstructured":"WHO, WHO Consultation on oral cholera vaccine (OCV) stockpile strategic framework: potential objectives and possible policy options: 18-20 September 2011, Geneva, Switzerland. 2012, World Health Organization: Geneva, Switzerland."},{"key":"10.1016\/j.vaccine.2021.12.015_b0075","unstructured":"IVI. IVI welcomes Bangladesh\u2019s accession to IVI. [cited 2021 29 March ]; Available from: https:\/\/www.ivi.int\/ivi-welcomes-bangladeshs-accession-to-ivi\/."},{"issue":"18","key":"10.1016\/j.vaccine.2021.12.015_b0080","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.12.015_b0085","doi-asserted-by":"crossref","unstructured":"Weil, A.A., et al., Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am J Tropical Medicine Hygiene, 2014. 91(4): p. 738-742.","DOI":"10.4269\/ajtmh.14-0095"},{"issue":"8","key":"10.1016\/j.vaccine.2021.12.015_b0090","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/IAI.71.8.4808-4814.2003","article-title":"Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers","volume":"71","author":"Qadri","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2021.12.015_b0095","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/iai.65.9.3571-3576.1997","article-title":"Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1","volume":"65","author":"Qadri","year":"1997","journal-title":"Infect Immun"},{"issue":"46","key":"10.1016\/j.vaccine.2021.12.015_b0100","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.015_b0105","unstructured":"Guidelines on clinical evaluation of vaccines: regulatory expectations. [cited 2021 27 March]; Available from: https:\/\/www.who.int\/biologicals\/publications\/trs\/areas\/vaccines\/clinical_evaluation\/en\/"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.015_b0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/wics.155","article-title":"Sample size calculations for clinical trials","volume":"3","author":"Chow","year":"2011","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"issue":"49","key":"10.1016\/j.vaccine.2021.12.015_b0115","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","article-title":"Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial","volume":"27","author":"Kanungo","year":"2009","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2021.12.015_b0120","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1016\/j.vaccine.2011.08.108","article-title":"Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age","volume":"29","author":"Saha","year":"2011","journal-title":"Vaccine"},{"issue":"9702","key":"10.1016\/j.vaccine.2021.12.015_b0125","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2021.12.015_b0130","unstructured":"WHO. Cholera vaccines: WHO position paper \u2013 August 2017. 2017 [cited 2021 18 November]; Available from: https:\/\/www.who.int\/publications\/i\/item\/cholera-vaccines-who-position-paper-august-2017."},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.015_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-518","article-title":"Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective","volume":"13","author":"Sarker","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.12.015_b0140","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1128\/IAI.72.8.4448-4454.2004","article-title":"The Major Subunit of the Toxin-Coregulated Pilus TcpA Induces Mucosal and Systemic Immunoglobulin A Immune Responses in Patients with Cholera Caused by <em>Vibrio cholerae<\/em> O1 and O139","volume":"72","author":"Asaduzzaman","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2021.12.015_b0145","unstructured":"WHO. [cited 2021 27 March]; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/Cholera."},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.015_b0150","doi-asserted-by":"crossref","first-page":"e2828","DOI":"10.1371\/journal.pntd.0002828","article-title":"Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti","volume":"8","author":"Charles","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.015_b0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/tmi.12641","article-title":"Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings","volume":"21","author":"Desai","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"10","key":"10.1016\/j.vaccine.2021.12.015_b0160","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1080\/21645515.2018.1460295","article-title":"Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia","volume":"14","author":"Teshome","year":"2018","journal-title":"Human Vaccines Immunotherapeutics"},{"issue":"14-15","key":"10.1016\/j.vaccine.2021.12.015_b0165","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0264-410X(98)00097-8","article-title":"Potential and limitations of polysaccharide vaccines in infancy","volume":"16","author":"Cadoz","year":"1998","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.015_b0170","doi-asserted-by":"crossref","first-page":"e96499","DOI":"10.1371\/journal.pone.0096499","article-title":"Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India","volume":"9","author":"Kanungo","year":"2014","journal-title":"PloS one"},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.015_b0175","doi-asserted-by":"crossref","first-page":"e0003574","DOI":"10.1371\/journal.pntd.0003574","article-title":"Flexibility of oral cholera vaccine dosing\u2014a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone","volume":"9","author":"Kanungo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2021.12.015_b0180","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/iai.61.9.3994-3997.1993","article-title":"Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels","volume":"61","author":"Gotuzzo","year":"1993","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.015_b0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/IAI.00868-09","article-title":"Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh","volume":"78","author":"Kendall","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2021.12.015_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/628963","article-title":"Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines","volume":"2008","author":"Klein Klouwenberg","year":"2008","journal-title":"Clin Developmental Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.015_b0195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/CVI.00336-07","article-title":"Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine","volume":"15","author":"Clutterbuck","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.12.015_b0200","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/CVI.05124-11","article-title":"Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh","volume":"18","author":"Leung","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"45","key":"10.1016\/j.vaccine.2021.12.015_b0205","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story\u2013Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.12.015_b0210","unstructured":"mondiale de la Sant\u00e9, O. and W.H. Organization, Cholera vaccines: WHO position paper\u2013August 2017\u2013Vaccins antichol\u00e9riques: Note de synth\u00e8se de l\u2019OMS\u2013ao\u00fbt 2017. Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire, 2017. 92(34): p. 477-498."},{"key":"10.1016\/j.vaccine.2021.12.015_b0215","unstructured":"WHO, Ending cholera a global roadmap to 2030, in Ending cholera a global roadmap to 2030. 2017. p. 32-32."},{"issue":"4","key":"10.1016\/j.vaccine.2021.12.015_b0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2471\/BLT.16.175166","article-title":"Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings","volume":"95","author":"Hsiao","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2021.12.015_b0225","doi-asserted-by":"crossref","unstructured":"Martin, S., A. Costa, and W. Perea, Stockpiling oral cholera vaccine. 2012, SciELO Public Health.","DOI":"10.2471\/BLT.12.112433"},{"key":"10.1016\/j.vaccine.2021.12.015_b0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coi.2021.03.009","article-title":"Supply and delivery of vaccines for global health","volume":"71","author":"Excler","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2021.12.015_b0235","doi-asserted-by":"crossref","unstructured":"Islam, M.T., J.D. Clemens, and F. Qadri, Cholera control and prevention in Bangladesh: an evaluation of the situation and solutions. J Infectious Diseases, 2018. 218(Suppl 3): p. S171.","DOI":"10.1093\/infdis\/jiy470"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:05:57Z","timestamp":1759403157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21016236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21016236"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}